NANOCOMPOSIX, INC.

Federal contract awards won by NANOCOMPOSIX, INC. (UEI EVQMBF7KC8P3), 2019–2022 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

4
awards
0
expiring in 12 months
1
agency

Agencies buying from NANOCOMPOSIX, INC.

Department of Health and Human Services (4)

What NANOCOMPOSIX, INC. has provided

541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) (2)541713 — RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY (1)541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) (1)

Awards

LATERAL FLOW ASSAY DEVICES
Department of Health and Human Services · $300,000 · Sep 28, 2022
THE OBJECTIVE OF THIS CONTRACT IS TO DESIGN AND SYNTHESIS A NEW PLGA BASED NANOPARTICLE WITH NANOPARTICLE WITH OPTIMAL PROTEIN-ADJUVANT FORMULATION COMBINING BOTH TARGETING AND CONTROLLED DELIVERY FOR IMMUNIZATION AGAINST HIV.
Department of Health and Human Services · $300,000 · Jun 1, 2020
THE OBJECTIVE IS TO DEVELOP CMV IGG AND IGM LATERAL FLOW ASSAYS REQUIRED TO SUPPORT A LARGE SCALE CMV VACCINATION TRIAL.
Department of Health and Human Services · $1,500,000 · Jul 31, 2019
THE OBJECTIVE OF THIS CONTRACT IS TO GENERATE AN EFFECTIVE HIV VACCINE USING THE TARGETED AND CONTROLLED DELIVERY OF ANTIGENS TO ANTIGEN PRESENTING CELLS (APC). ENGINEERED NANOPARTICLES LOADED WITH MRNA CAPTURED BEHIND PH SENSITIVE POLYMER, TARGETED WITH MANNOSE WILL BE EMPLOYED TO INDUCE A HIV-SPECIFIC AND CELLULAR IMMUNE RESPONSE.
Department of Health and Human Services · $600,000 · Jun 17, 2019